Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

Incidence of rhegmatogenous retinal detachments following intravitreal injections

Harry Dang; Rajeev H Muni; Robert G Devenyi; Wai-Ching Lam; Kenneth Eng; Carol E Schwartz; Radha P Kohly; Peter J Kertes

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2309. doi:

ARVO Annual Meeting Abstract April 2014

Outcome of surgical excision and histopathologcial features of cyclitc membranes in children

Mostafa A Elgohary; Pear Pongsachareonnont; Rajeev H Muni; Peter J Kertes; Wai-Ching Lam; Asim Ali

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2325. doi:

ARVO Annual Meeting Abstract March 2012

Spectral-Domain OCT Monitoring in Patients with Choroidal Neovascularization Secondary to Age-related Macular Degeneration, a Lucentis Outcomes Pilot Program (HOLOGRAM): 12-month results

Fareed A. Ali; Eric Tourville; John C. Chen; Peter J. Kertes; Bonita Rehel; Frederica De Takacsy; Ruihong Li

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2923. doi:

Clinical and Epidemiologic Research May 2010

Alterations in the Intraocular Cytokine Milieu after Intravitreal Bevacizumab

PDF

Farzin Forooghian; Peter J. Kertes; Kenneth T. Eng; Elvira Agrón; Emily Y. Chew
TAGS: bevacizumab, cytokine
Invest. Ophthalmol. Vis. Sci.. 2010; 51(5):2388-2392. doi: https://doi.org/10.1167/iovs.09-4065

Advertisement